Cargando…
国产达沙替尼治疗新诊断的慢性髓性白血病慢性期患者疗效及安全性分析
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364929/ https://www.ncbi.nlm.nih.gov/pubmed/32447937 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.04.011 |
| _version_ | 1783559935863291904 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7364929 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Editorial office of Chinese Journal of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73649292020-07-16 国产达沙替尼治疗新诊断的慢性髓性白血病慢性期患者疗效及安全性分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2020-04 /pmc/articles/PMC7364929/ /pubmed/32447937 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.04.011 Text en 2020年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal. |
| spellingShingle | 短篇论著 国产达沙替尼治疗新诊断的慢性髓性白血病慢性期患者疗效及安全性分析 |
| title | 国产达沙替尼治疗新诊断的慢性髓性白血病慢性期患者疗效及安全性分析 |
| title_full | 国产达沙替尼治疗新诊断的慢性髓性白血病慢性期患者疗效及安全性分析 |
| title_fullStr | 国产达沙替尼治疗新诊断的慢性髓性白血病慢性期患者疗效及安全性分析 |
| title_full_unstemmed | 国产达沙替尼治疗新诊断的慢性髓性白血病慢性期患者疗效及安全性分析 |
| title_short | 国产达沙替尼治疗新诊断的慢性髓性白血病慢性期患者疗效及安全性分析 |
| title_sort | 国产达沙替尼治疗新诊断的慢性髓性白血病慢性期患者疗效及安全性分析 |
| topic | 短篇论著 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364929/ https://www.ncbi.nlm.nih.gov/pubmed/32447937 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.04.011 |
| work_keys_str_mv | AT guóchǎndáshātìnízhìliáoxīnzhěnduàndemànxìngsuǐxìngbáixuèbìngmànxìngqīhuànzhěliáoxiàojíānquánxìngfēnxī AT guóchǎndáshātìnízhìliáoxīnzhěnduàndemànxìngsuǐxìngbáixuèbìngmànxìngqīhuànzhěliáoxiàojíānquánxìngfēnxī AT guóchǎndáshātìnízhìliáoxīnzhěnduàndemànxìngsuǐxìngbáixuèbìngmànxìngqīhuànzhěliáoxiàojíānquánxìngfēnxī AT guóchǎndáshātìnízhìliáoxīnzhěnduàndemànxìngsuǐxìngbáixuèbìngmànxìngqīhuànzhěliáoxiàojíānquánxìngfēnxī AT guóchǎndáshātìnízhìliáoxīnzhěnduàndemànxìngsuǐxìngbáixuèbìngmànxìngqīhuànzhěliáoxiàojíānquánxìngfēnxī AT guóchǎndáshātìnízhìliáoxīnzhěnduàndemànxìngsuǐxìngbáixuèbìngmànxìngqīhuànzhěliáoxiàojíānquánxìngfēnxī AT guóchǎndáshātìnízhìliáoxīnzhěnduàndemànxìngsuǐxìngbáixuèbìngmànxìngqīhuànzhěliáoxiàojíānquánxìngfēnxī |